Citadel Advisors
SLDB icon

Citadel Advisors’s Solid Biosciences SLDB Stock Holding History

Citadel Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134K Buy
+18,600
New +$120K ﹤0.01% 11783
2025
Q4 		– Sell
-23,300
Closed -$144K – 13953
2025
Q3 		$144K Sell
23,300
-3,200
-12% -$18.7K ﹤0.01% 11561
2025
Q2 		$129K Sell
26,500
-18,800
-42% -$66.5K ﹤0.01% 11101
2025
Q1 		$168K Buy
45,300
+35,700
+372% +$153K ﹤0.01% 10700
2024
Q4 		$38.4K Buy
9,600
+3,200
+50% +$17.6K ﹤0.01% 12649
2024
Q3 		$44.6K Buy
6,400
+5,300
+482% +$43K ﹤0.01% 12039
2024
Q2 		$6.24K Sell
1,100
-10,600
-91% -$94.9K ﹤0.01% 13348
2024
Q1 		$156K Buy
+11,700
New +$109K ﹤0.01% 10713
2023
Q2 		– Sell
-390
Closed -$1.85K – 15143
2023
Q1 		$1.85K Buy
+390
New +$2.34K ﹤0.01% 14240
2022
Q1 		– Sell
-767
Closed -$20K – 14486
2021
Q4 		$20K Sell
767
-3,140
-80% -$96K ﹤0.01% 13586
2021
Q3 		$140K Buy
3,907
+934
+31% +$39.7K ﹤0.01% 12459
2021
Q2 		$163K Sell
2,973
-4,040
-58% -$267K ﹤0.01% 12407
2021
Q1 		$582K Buy
7,013
+5,546
+378% +$614K ﹤0.01% 9352
2020
Q4 		$167K Buy
+1,467
New +$92.8K ﹤0.01% 9874
2020
Q2 		– Sell
-1,640
Closed -$59K – 10441
2020
Q1 		$59K Sell
1,640
-1,020
-38% -$50.5K ﹤0.01% 8953
2019
Q4 		$178K Buy
2,660
+1,087
+69% +$120K ﹤0.01% 8262
2019
Q3 		$244K Buy
1,573
+826
+111% +$93.5K ﹤0.01% 7873
2019
Q2 		$64K Sell
747
-220
-23% -$24K ﹤0.01% 8661
2019
Q1 		$133K Buy
+967
New +$242K ﹤0.01% 8439

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors's SLDB Position: Q1 2026 in Review

Citadel Advisors reduced its Solid Biosciences (SLDB) stake by 2.5% in Q1 2026, selling an estimated $431K and leaving 2,596,800 shares worth $18.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2404.

Citadel Advisors first reported a position in SLDB in Q1 2018 and has held it in 25 quarters since. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Citadel Advisors held 2,596,800 shares of Solid Biosciences worth $18.7M as of Q1 2026.
  • Citadel Advisors sold 67,063 Solid Biosciences shares in Q1 2026, an estimated $431K.
  • Solid Biosciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2404 holding.
  • Citadel Advisors first reported a position in Solid Biosciences in Q1 2018 and has held it in 25 quarters since.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.